bioRxiv Science⌕ Search

Biology subjects

Jana, S. K.

Publications and source records attributed to Jana, S. K..

2 recordsLinked to original sources

A Novel MicroRNA-Odorant Receptor Axis Governs Neural Progenitor Cell Proliferation in Zebrafish CNS

Spinal cord injury causes irreversible neurological deficits in mammals; yet zebrafish achieve complete functional recovery through molecular mechanisms that remain poorly defined. In this study we emphasized on a critical miRNA-mediated regulation of Ependymo-radial glial (ERG) cell proliferation in zebrafish spinal cord. Using next-generation sequencing we constructed a spatiotemporal miRNA profile across multiple post-injury time points and identified dre-miR-N1 as a novel injury-responsive miRNA involved in ERG proliferation among several differentially expressed novel miRNAs. Fluorescent in situ hybridization confirmed its robust lesion-site expression and gain-of-function analysis demonstrated that dre-miR-N1 significantly impaired functional recovery. Target prediction and validation unexpectedly identified the odorant receptor gene or42a1 as a high-confidence target and a combinatorial approach of miRNA gain-of-function and or42a1 loss-of-function showed that dre-miR-N1 modulates the proliferative behaviour of or42a1-expressing ERG cells under both homeostatic and injury conditions. These findings uncover a previously unrecognized miRNA-odorant receptor axis governing injury-induced ERG cell expansion establishing a novel molecular framework for endogenous neural regeneration in zebrafish.

neuroscience↗

Chemical control of 2'-hydroxyl-dependent Cas9 target engagement enables CRISPR RNA ribose replacement

Advanced CRISPR-based therapies benefit from CRISPR RNA (crRNA) with high nuclease resistance and enhanced drug-like properties, which is primarily achieved through chemical replacement of the RNA ribose moiety. However, for gene editing enzymes like CRISPR-Cas9 a handful of residues cannot be replaced with chemical ribose analogues, limiting the scope of therapeutic strategies. The mechanism underlying this restriction has remained unclear. Here, using nucleic acid chemistry, biochemistry, cryo-EM, and molecular dynamics simulations, we show that the ribose 2-hydroxyl group at specific crRNA residues is required to achieve a conformational state competent for Cas9 target DNA binding. Based on the mechanistic principles uncovered, we combined site-specific phosphorothioate linkage chemistry with ribose replacement chemistry to restore binding and activity, resulting in high Cas9 editing efficiency and fidelity with a ribose-free crRNA. This study offers novel mechanistic insight and crRNAs with full chemical stabilization, making rational design of guide RNAs with complete nuclease protection for CRISPR-based medicines possible.

biochemistry↗